Fabienne Vacheret

Perpignan, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Thromboinflammation is associated with high thrombotic risk in patients with newly diagnosed myeloproliferative neoplasms.

Thromboinflammation is associated with high thrombotic risk in patients with newly diagnosed myeloproliferative neoplasms.

Journal: Leukemia

Published: August 20, 2025

Thromboinflammation is associated with high thrombotic risk in patients with newly diagnosed myeloproliferative neoplasms.

Thromboinflammation is associated with high thrombotic risk in patients with newly diagnosed myeloproliferative neoplasms.

Journal: Leukemia

Published: August 20, 2025

A molecular signature predicts hematologic evolution in polycythemia vera patients.

A molecular signature predicts hematologic evolution in polycythemia vera patients.

Journal: Leukemia

Published: April 03, 2025

Efficacy and safety of Anakinra in idiopathic recurrent pericarditis: Results from the UPACITER study.

Efficacy and safety of Anakinra in idiopathic recurrent pericarditis: Results from the UPACITER study.

Journal: International journal of cardiology

Published: February 19, 2025

Isolated intraocular relapses of primary cerebral lymphomas: An LOC network study.

Isolated intraocular relapses of primary cerebral lymphomas: An LOC network study.

Journal: Hematological oncology

Published: March 08, 2022

Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study.

Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study.

Journal: Blood advances

Published: September 18, 2020

Iatrogenic acquired factor V inhibitors: A case report and review of the French pharmacovigilance database.

Iatrogenic acquired factor V inhibitors: A case report and review of the French pharmacovigilance database.

Journal: Thrombosis research

Published: March 25, 2017

New prognostic markers, determined using gene expression analyses, reveal two distinct subtypes of chronic myelomonocytic leukaemia patients.

New prognostic markers, determined using gene expression analyses, reveal two distinct subtypes of chronic myelomonocytic leukaemia patients.

Journal: British journal of haematology

Published: December 01, 2011

Showing 1-8 of 8

Last Updated: 09/26/2026